Cullen Investment Group, Ltd. Gilead Sciences, Inc. Transaction History
Cullen Investment Group, Ltd.
- $678 Billion
- Q4 2024
A detailed history of Cullen Investment Group, Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 15,808 shares of GILD stock, worth $1.7 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
15,808
Previous 16,323
3.16%
Holding current value
$1.7 Million
Previous $1.37 Billion
6.7%
% of portfolio
0.22%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,086Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.4 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.72 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.5 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.24 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...